Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Vaccinex's shares outstanding was 3M at Dec 31, 2024. For fiscal 2024 it was 2M, up 352.7% from the year before. The highest annual figure on record is 2M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 2M | +352.7% |
| FY2023 | Dec 31, 2023 | 0M | +129.4% |
| FY2022 | Dec 31, 2022 | 0M | +47.1% |
| FY2021 | Dec 31, 2021 | 0M | +53.6% |
| FY2020 | Dec 31, 2020 | 0M | +45.9% |
| FY2019 | Dec 31, 2019 | 0M | +146.6% |
| FY2018 | Dec 31, 2018 | 0M | +374.1% |
| FY2017 | Dec 31, 2017 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | 3M | +900.6% |
| Q3 FY2024 | Sep 30, 2024 | 2M | +604.5% |
| Q2 FY2024 | Jun 30, 2024 | 2M | +665.2% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +510.4% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +58.6% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +41.6% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +28.7% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +48.2% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +38.5% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +49.3% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +53.7% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +37.6% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +53.4% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +71.2% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +57.6% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +51.4% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +45.9% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +45.4% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +39.4% |
| Q4 FY2019 | Dec 31, 2019 | 0M | +108.8% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +1147.3% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +941.2% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +940.9% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +542.1% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +0.1% |
| Q1 FY2018 | Mar 31, 2018 | 0M | – |
| Q4 FY2017 | Dec 31, 2017 | 0M | – |
| Q3 FY2017 | Sep 30, 2017 | 0M | – |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
See a number that looks wrong?